HK1058361A1
(en )
2004-05-14
Urea derivatives as integrin alpha 4 antagonists
IL164135A0
(en )
2005-12-18
4-Anilino quinazoline derivatives as antirpoliferative agents
HK1052343A1
(en )
2004-02-06
Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
AU2002358700A8
(en )
2003-07-15
Urea derivatives as vr1- antagonists
IL169336A0
(en )
2007-07-04
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
HK1084394A1
(en )
2006-07-28
Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use for preparing neurokinin antagonists
EP1539735A4
(en )
2006-07-26
Piperazine urea derivatives as melanocortin-4 receptor agonists
PL374758A1
(en )
2005-10-31
Methylene urea derivatives
HK1111417A1
(en )
2008-08-08
Quinazoline derivatives
GB0215823D0
(en )
2002-08-14
Quinazoline derivatives
IL165841A0
(en )
2006-01-15
Mchir antagonists
HK1088910A1
(en )
2006-11-17
Substituted diketopiperazines and their use as oxytocyn antagonists
AU2002352476A8
(en )
2003-07-09
Urea derivatives and their use as vanilloid receptor antagonists
AU2003202091A8
(en )
2003-06-10
Guanidine derivatives
PL1667668T3
(en )
2008-10-31
Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
AU2541000A
(en )
2000-08-01
Beta-phenylalanine derivatives as integrin antagonists
ZA200610455B
(en )
2007-11-28
4-Anilino Quinazoline derivatives as antiproliferative agents
HK1087924A1
(en )
2006-10-27
Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
NO20015237L
(en )
2001-12-21
Integrin antagonists
SI1558259T1
(en )
2011-06-30
Urea derivatives as IL-8 receptor antagonists
TWI320409B
(en )
2010-02-11
Urea derivatives as integrin 4 antagonists
PL374817A1
(en )
2005-10-31
Quinazoline derivatives
EP1169042A4
(en )
2003-05-02
Dibenzo-azepine derivatives as alpha v integrin receptor antagonists
SI1383750T1
(en )
2008-02-29
Urea derivatives as integrin alpha 4 antagonists
PL376403A1
(en )
2005-12-27
Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists